EP3057567A2 - Produits cosmétiques anti-transpirants aux alpha-hydroxyacides - Google Patents
Produits cosmétiques anti-transpirants aux alpha-hydroxyacidesInfo
- Publication number
- EP3057567A2 EP3057567A2 EP14796688.1A EP14796688A EP3057567A2 EP 3057567 A2 EP3057567 A2 EP 3057567A2 EP 14796688 A EP14796688 A EP 14796688A EP 3057567 A2 EP3057567 A2 EP 3057567A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- aluminum
- antiperspirant
- cosmetic agent
- weight
- antiperspirant cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 286
- 230000001166 anti-perspirative effect Effects 0.000 title claims abstract description 284
- 239000002537 cosmetic Substances 0.000 title claims abstract description 169
- 150000001280 alpha hydroxy acids Chemical class 0.000 title claims abstract description 75
- 229940061720 alpha hydroxy acid Drugs 0.000 title claims abstract description 65
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims abstract description 108
- 239000003921 oil Substances 0.000 claims abstract description 35
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 239000001993 wax Substances 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims description 55
- -1 siloxane units Chemical group 0.000 claims description 49
- 229910052782 aluminium Inorganic materials 0.000 claims description 43
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 41
- 125000004432 carbon atom Chemical group C* 0.000 claims description 35
- 150000003839 salts Chemical class 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000011734 sodium Substances 0.000 claims description 26
- 229920002545 silicone oil Polymers 0.000 claims description 21
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 claims description 19
- 229920006395 saturated elastomer Polymers 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 239000000194 fatty acid Substances 0.000 claims description 17
- DNXNYEBMOSARMM-UHFFFAOYSA-N alumane;zirconium Chemical class [AlH3].[Zr] DNXNYEBMOSARMM-UHFFFAOYSA-N 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 150000004665 fatty acids Chemical class 0.000 claims description 15
- 239000003205 fragrance Substances 0.000 claims description 15
- 101001083370 Dictyostelium discoideum Hisactophilin-1 Proteins 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 10
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 7
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 7
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Chemical compound CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 4
- LEEDMQGKBNGPDN-UHFFFAOYSA-N Isoeicosane Natural products CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 claims description 4
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical class CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 4
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000539 dimer Substances 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- CJBFZKZYIPBBTO-UHFFFAOYSA-N isotetradecane Natural products CCCCCCCCCCCC(C)C CJBFZKZYIPBBTO-UHFFFAOYSA-N 0.000 claims description 4
- HGEMCUOAMCILCP-UHFFFAOYSA-N isotridecane Natural products CCCCCCCCCCC(C)C HGEMCUOAMCILCP-UHFFFAOYSA-N 0.000 claims description 4
- 210000004243 sweat Anatomy 0.000 claims description 4
- 235000013769 triethyl citrate Nutrition 0.000 claims description 4
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 229910052738 indium Inorganic materials 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 230000005068 transpiration Effects 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- BDEHGQOUMOLWCN-UHFFFAOYSA-N 16-methylheptadecyl benzoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 BDEHGQOUMOLWCN-UHFFFAOYSA-N 0.000 claims description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 2
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 claims description 2
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229920002367 Polyisobutene Polymers 0.000 claims description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 2
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 2
- YCLAMANSVUJYPT-UHFFFAOYSA-L aluminum chloride hydroxide hydrate Chemical compound O.[OH-].[Al+3].[Cl-] YCLAMANSVUJYPT-UHFFFAOYSA-L 0.000 claims description 2
- 229940053431 aluminum sesquichlorohydrate Drugs 0.000 claims description 2
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 claims description 2
- XNLYYQDZUNCJRA-UHFFFAOYSA-N aluminum;hypobromous acid Chemical compound [Al].BrO XNLYYQDZUNCJRA-UHFFFAOYSA-N 0.000 claims description 2
- SJXYSRSHDPPYIU-UHFFFAOYSA-L aluminum;propane-1,2-diol;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].CC(O)CO SJXYSRSHDPPYIU-UHFFFAOYSA-L 0.000 claims description 2
- YAKZEVHORUHNLS-UHFFFAOYSA-K aluminum;sodium;2-hydroxypropanoate;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Na+].[Al+3].[Cl-].CC(O)C([O-])=O YAKZEVHORUHNLS-UHFFFAOYSA-K 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims description 2
- SFHUSLFRIKHKPE-UHFFFAOYSA-L chloro-[(2,5-dioxoimidazolidin-4-yl)carbamoylamino]aluminum;hydrate Chemical compound O.NC(=O)NC1NC(=O)N([Al]Cl)C1=O SFHUSLFRIKHKPE-UHFFFAOYSA-L 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- DDJSWKLBKSLAAZ-UHFFFAOYSA-N cyclotetrasiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]1 DDJSWKLBKSLAAZ-UHFFFAOYSA-N 0.000 claims description 2
- JJRDHFIVAPVZJN-UHFFFAOYSA-N cyclotrisiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]1 JJRDHFIVAPVZJN-UHFFFAOYSA-N 0.000 claims description 2
- XILPPDQAWPSZIL-UHFFFAOYSA-H dialuminum;dichloride;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-] XILPPDQAWPSZIL-UHFFFAOYSA-H 0.000 claims description 2
- KNXDJTLIRRQLBE-UHFFFAOYSA-H dialuminum;propane-1,2-diol;chloride;pentahydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].CC(O)CO KNXDJTLIRRQLBE-UHFFFAOYSA-H 0.000 claims description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 claims description 2
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 2
- 229940057995 liquid paraffin Drugs 0.000 claims description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 claims description 2
- LNRUVXAPKCPQGX-UHFFFAOYSA-N 2-octyldodecyl benzoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)C1=CC=CC=C1 LNRUVXAPKCPQGX-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims 1
- 238000004018 waxing Methods 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract description 20
- 230000006641 stabilisation Effects 0.000 abstract description 16
- 238000011105 stabilization Methods 0.000 abstract description 16
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 description 26
- 230000000694 effects Effects 0.000 description 21
- 229920000642 polymer Polymers 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000003380 propellant Substances 0.000 description 18
- 229940060184 oil ingredients Drugs 0.000 description 16
- 239000007921 spray Substances 0.000 description 15
- 239000011575 calcium Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000011701 zinc Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 239000003586 protic polar solvent Substances 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 239000003995 emulsifying agent Substances 0.000 description 10
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 239000002781 deodorant agent Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940041616 menthol Drugs 0.000 description 7
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 7
- 239000007764 o/w emulsion Substances 0.000 description 7
- 229960004063 propylene glycol Drugs 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 239000007762 w/o emulsion Substances 0.000 description 7
- 244000303965 Cyamopsis psoralioides Species 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000001294 propane Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000004604 Blowing Agent Substances 0.000 description 5
- 241001440269 Cutina Species 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000001282 iso-butane Substances 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001273 butane Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 229940086555 cyclomethicone Drugs 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 3
- CGMOOAUESLSUKM-UHFFFAOYSA-N 2-benzylheptan-1-ol Chemical compound CCCCCC(CO)CC1=CC=CC=C1 CGMOOAUESLSUKM-UHFFFAOYSA-N 0.000 description 3
- MDVYIGJINBYKOM-IBSWDFHHSA-N 3-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxypropane-1,2-diol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(O)CO MDVYIGJINBYKOM-IBSWDFHHSA-N 0.000 description 3
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002563 ionic surfactant Substances 0.000 description 3
- 229940095045 isopulegol Drugs 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229910052726 zirconium Inorganic materials 0.000 description 3
- 239000002888 zwitterionic surfactant Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RMFFCSRJWUBPBJ-UHFFFAOYSA-N 15-hydroxypentadecyl benzoate Chemical compound OCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RMFFCSRJWUBPBJ-UHFFFAOYSA-N 0.000 description 2
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- FLUWAIIVLCVEKF-UHFFFAOYSA-N 2-Methyl-1-phenyl-2-propanyl acetate Chemical compound CC(=O)OC(C)(C)CC1=CC=CC=C1 FLUWAIIVLCVEKF-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- YIMQCDZDWXUDCA-ZKCHVHJHSA-N OC[C@H]1CC[C@H](CO)CC1 Chemical compound OC[C@H]1CC[C@H](CO)CC1 YIMQCDZDWXUDCA-ZKCHVHJHSA-N 0.000 description 2
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical class OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229940011037 anethole Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 229940095104 dimethyl benzyl carbinyl acetate Drugs 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940099563 lactobionic acid Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001147 (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran Substances 0.000 description 1
- IFQAUICFVCGLJL-NWDWNXPCSA-N (4r)-4-[(3s,5s,7r,8r,9s,10s,12s,13r,17r)-3-azido-7,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-n-[2-(2-iodo-1h-imidazol-5-yl)ethyl]pentanamide Chemical compound C([C@@H](C)[C@@H]1[C@]2([C@@H](O)C[C@@H]3[C@@]4(C)CC[C@@H](C[C@H]4C[C@@H](O)[C@H]3C2CC1)N=[N+]=[N-])C)CC(=O)NCCC1=CN=C(I)N1 IFQAUICFVCGLJL-NWDWNXPCSA-N 0.000 description 1
- FMATXKUIGQODAH-UHFFFAOYSA-N (5-methyl-2-propan-2-ylcyclohexyl) 2-hydroxyacetate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CO FMATXKUIGQODAH-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YYMCVDNIIFNDJK-XFQWXJFMSA-N (z)-1-(3-fluorophenyl)-n-[(z)-(3-fluorophenyl)methylideneamino]methanimine Chemical compound FC1=CC=CC(\C=N/N=C\C=2C=C(F)C=CC=2)=C1 YYMCVDNIIFNDJK-XFQWXJFMSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- WCIQNYOXLZQQMU-UHFFFAOYSA-N 1-Phenylethyl propanoate Chemical compound CCC(=O)OC(C)C1=CC=CC=C1 WCIQNYOXLZQQMU-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- JVONGXDERNPTPQ-UHFFFAOYSA-N 2-(hydroxymethyl)-3,5,5-trimethylcyclohexan-1-ol Chemical compound CC1CC(C)(C)CC(O)C1CO JVONGXDERNPTPQ-UHFFFAOYSA-N 0.000 description 1
- MJTPMXWJHPOWGH-UHFFFAOYSA-N 2-Phenoxyethyl isobutyrate Chemical compound CC(C)C(=O)OCCOC1=CC=CC=C1 MJTPMXWJHPOWGH-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 1
- BYACHAOCSIPLCM-UHFFFAOYSA-N 2-[2-[bis(2-hydroxyethyl)amino]ethyl-(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)CCN(CCO)CCO BYACHAOCSIPLCM-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- QOPUBSBYMCLLKW-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-4-hydroxybutanoic acid Chemical compound OCCC(C(O)=O)N(CC(O)=O)CCN(CC(O)=O)CC(O)=O QOPUBSBYMCLLKW-UHFFFAOYSA-N 0.000 description 1
- ZJVJPPNOQCMEPI-UHFFFAOYSA-N 2-[ethyl(methyl)amino]-2-phenylacetic acid Chemical compound CCN(C)C(C(O)=O)C1=CC=CC=C1 ZJVJPPNOQCMEPI-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- UWRBFYBQPCJRRL-UHFFFAOYSA-N 3-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CC(O)=O)CC(O)=O UWRBFYBQPCJRRL-UHFFFAOYSA-N 0.000 description 1
- YHQXBTXEYZIYOV-UHFFFAOYSA-N 3-methylbut-1-ene Chemical compound CC(C)C=C YHQXBTXEYZIYOV-UHFFFAOYSA-N 0.000 description 1
- UNDXPKDBFOOQFC-UHFFFAOYSA-N 4-[2-nitro-4-(trifluoromethyl)phenyl]morpholine Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1N1CCOCC1 UNDXPKDBFOOQFC-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MBZRJSQZCBXRGK-UHFFFAOYSA-N 4-tert-Butylcyclohexyl acetate Chemical compound CC(=O)OC1CCC(C(C)(C)C)CC1 MBZRJSQZCBXRGK-UHFFFAOYSA-N 0.000 description 1
- LEGVTAFKUDAZRE-UHFFFAOYSA-N 5-ethylnonane-1,2,3-triol Chemical compound CCCCC(CC)CC(O)C(O)CO LEGVTAFKUDAZRE-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- RNIHAPSVIGPAFF-UHFFFAOYSA-N Acrylamide-acrylic acid resin Chemical compound NC(=O)C=C.OC(=O)C=C RNIHAPSVIGPAFF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000009133 Arylsulfatases Human genes 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical class OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- BLILOGGUTRWFNI-UHFFFAOYSA-N Monomenthyl succinate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(O)=O BLILOGGUTRWFNI-UHFFFAOYSA-N 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical class OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Chemical class OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- LMETVDMCIJNNKH-UHFFFAOYSA-N [(3,7-Dimethyl-6-octenyl)oxy]acetaldehyde Chemical compound CC(C)=CCCC(C)CCOCC=O LMETVDMCIJNNKH-UHFFFAOYSA-N 0.000 description 1
- ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical class [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- UWLPQOYXSVQJFO-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].NC1CCOP(=O)O1 Chemical compound [Na].[Na].[Na].[Na].[Na].NC1CCOP(=O)O1 UWLPQOYXSVQJFO-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- ZLUOHLNAAZHALG-UHFFFAOYSA-N acetyl 2-hydroxypropanoate Chemical compound CC(O)C(=O)OC(C)=O ZLUOHLNAAZHALG-UHFFFAOYSA-N 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- QUMXDOLUJCHOAY-UHFFFAOYSA-N alpha-methylbenzyl acetate Natural products CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- WWHZEXDIQCJXSV-UHFFFAOYSA-N aluminum;trihypochlorite Chemical compound [Al+3].Cl[O-].Cl[O-].Cl[O-] WWHZEXDIQCJXSV-UHFFFAOYSA-N 0.000 description 1
- DSYJRMUHBOOQPV-UHFFFAOYSA-G aluminum;zirconium(4+);heptachloride Chemical class [Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Zr+4] DSYJRMUHBOOQPV-UHFFFAOYSA-G 0.000 description 1
- YPZUZOLGGMJZJO-LQKXBSAESA-N ambroxan Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@]2(C)OCC1 YPZUZOLGGMJZJO-LQKXBSAESA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- FZJUFJKVIYFBSY-UHFFFAOYSA-N bourgeonal Chemical compound CC(C)(C)C1=CC=C(CCC=O)C=C1 FZJUFJKVIYFBSY-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940073642 ceteareth-30 Drugs 0.000 description 1
- 229940005759 cetyl behenate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940019836 cyclamen aldehyde Drugs 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- NUQDJSMHGCTKNL-UHFFFAOYSA-N cyclohexyl 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OC1CCCCC1 NUQDJSMHGCTKNL-UHFFFAOYSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 229940106055 dodecyl benzoate Drugs 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RZMZBHSKPLVQCP-UHFFFAOYSA-N ethyl 2-amino-2-oxoacetate Chemical compound CCOC(=O)C(N)=O RZMZBHSKPLVQCP-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 125000001924 fatty-acyl group Chemical group 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- UKACHOXRXFQJFN-UHFFFAOYSA-N heptafluoropropane Chemical compound FC(F)C(F)(F)C(F)(F)F UKACHOXRXFQJFN-UHFFFAOYSA-N 0.000 description 1
- UEDYHQHDUXDFGA-UHFFFAOYSA-N hexadecyl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC UEDYHQHDUXDFGA-UHFFFAOYSA-N 0.000 description 1
- BHXOBVQQGGHPJY-UHFFFAOYSA-N hexadecyl octadecanoate;octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC BHXOBVQQGGHPJY-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- WMIYKQLTONQJES-UHFFFAOYSA-N hexafluoroethane Chemical compound FC(F)(F)C(F)(F)F WMIYKQLTONQJES-UHFFFAOYSA-N 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical class CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical class CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 239000013628 high molecular weight specie Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- GAQPWOABOQGPKA-UHFFFAOYSA-N octadecyl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCC GAQPWOABOQGPKA-UHFFFAOYSA-N 0.000 description 1
- TZXYSEYEGNHPQI-UHFFFAOYSA-N octadecyl dodecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCC TZXYSEYEGNHPQI-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- QPTMDBQLCWRDCK-UHFFFAOYSA-I pentasodium;[2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP(O)([O-])=O)CCN(CP(O)([O-])=O)CP([O-])([O-])=O QPTMDBQLCWRDCK-UHFFFAOYSA-I 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920013639 polyalphaolefin Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 229940079053 quaternium-27 Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229940080258 tetrasodium iminodisuccinate Drugs 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 1
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Definitions
- the present invention relates to an antiperspirant cosmetic agent which contains at least one antiperspirant aluminum salt and at least one alpha-hydroxy acid and wherein the addition of the at least one alpha-hydroxy acid results in an effective activation of the at least one antiperspirant aluminum salt and in a stabilization of this activated state.
- the present invention relates to the use of a combination of at least one antiperspirant aluminum salt and at least one alpha-hydroxy acid for reducing and / or preventing underarm perspiration.
- the present invention relates to a non-therapeutic cosmetic method for preventing and / or reducing transpiration of the body, in which the antiperspirant according to the invention is applied to the skin, in particular to the skin of the armpits.
- the present invention relates to the use of an alpha-hydroxy acid for the activation and / or stabilization of an antiperspirant aluminum salt.
- washing, cleansing and caring for one's own body is a basic human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor and underarm wetness.
- Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as impregnated flexible substrates (towels).
- Prior art cosmetic antiperspirants contain at least one antiperspirant salt in addition to at least one oil or fatty substance and one perfume component or perfume.
- basic aluminum and aluminum zirconium halides are used in the form of chlorides, as they have no irritating effect, unlike the non-basic aluminum and aluminum zirconium chlorides.
- the disadvantage of the basic aluminum and aluminum zirconium halides is the formation of higher molecular weight oligomeric and polymeric aluminum species, which significantly reduce the effectiveness of the basic aluminum and aluminum zirconium salts in antiperspirants.
- EP 0 308 937 A2, EP 0 183 171 A2, US Pat. No. 4,359,456 A and EP 0 191 628 A2 describe basic aluminum and aluminum zirconium halides, in particular aluminum chlorides, which have been obtained by a thermal treatment.
- the heat-treated activated basic aluminum and aluminum zirconium halides have a lower content of high molecular weight species in gel permeation chromatography (GPC) compared to untreated basic aluminum and aluminum zirconium halides and thus enhanced antiperspirant efficacy against antiperspirants.
- GPC gel permeation chromatography
- a disadvantage of the aforementioned activated basic aluminum and aluminum zirconium halides of the prior art is the decrease in the antiperspirant effect with increasing storage time and / or when using protic solvents. This is due to the fact that the polymer distribution of the aluminum species is based on a reversible equilibrium and shifts this equilibrium in protic solvents with increasing time to higher molecular weight and thus less effective aluminum species.
- antiperspirant cosmetic products which, even during long storage periods and / or when using high amounts of protic solvents, have no shift in the polymer distribution to long-chain polymers and thus no significant decrease in the antiperspirant effect. Furthermore, the antiperspirants should be inexpensive to produce.
- the subject of the present invention is thus an antiperspirant cosmetic containing
- R is a linear or branched alkyl group having 1 to 6 carbon atoms
- R 2 , R 3 , R 4 and R 5 each independently represent hydrogen, -OH, a linear or branched alkyl group having 1 to 8 carbon atoms, an alkoxy group 1 to 6 carbon atoms, -NH 2, a galactopyranose residue or a galactopyranose residue partially or fully alkoxylated with ⁇ -6-alkyl groups
- R 7 , R 8 , R 9 and R 0 each independently of one another, represent hydrogen, an alkoxy group having 1 to 6 carbon atoms or -OH,
- y is a number from 0 to 5
- X + for H + Li + , Na + , K + , NH 4 + , 7 2 Mg 2+ , 7 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 "or at least one antiperspirant aluminum salt, and
- Y + is Li + , Na + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 "or at least one antiperspirant aluminum salt .
- X + is Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , 4 Zr 4 * or at least one antiperspirant aluminum salt is when R 4 is a Galactopyranoserest.
- antiperspirant aluminum salts with special alpha hydroxy acids of the formulas (HS-I) and / or (HS-II) and / or (HS-III) is - without wishing to be limited to this theory - a significant increase in the proportion achieved on short-chain species of antiperspirant aluminum salts. Furthermore, the thus formed short-chain species are excellently stabilized by the aforementioned alpha-hydroxy acids, so that an improved antiperspirant effect is ensured over a long period of time.
- the use of the special alpha-hydroxy acids makes it possible, in particular, to prepare antiperspirants with a high proportion of protic solvents which, despite the high amounts of protic solvents, have an excellent antiperspirant effect even during prolonged storage periods.
- antiperspirant is understood according to the invention to reduce or reduce the perspiration of the sweat glands of the body.
- cosmetic oil in the sense of the present invention is understood as meaning an oil which is suitable for cosmetic use and which is immiscible with water.Furthermore, the cosmetic oil used according to the invention is neither fragrance nor essential oils.
- fragments in the context of the present invention means substances having a molecular weight of 74 to 300 g / mol, which contain at least one osmophoric group in the molecule and have an odor and / or taste, ie they are able to Osmophore groups are groups covalently bound to the molecular skeleton in the form of hydroxy groups, formyl groups, oxo groups, alkoxycarbonyl groups, nitrile groups, nitro groups, azide groups, etc.
- fragments within the meaning of present invention even at 20 ° C and 1013 hPa liquid perfume oils, perfumes, or perfume oil ingredients.
- the term "waxes" in the context of the present invention means substances which are kneadable at 20 ° C. or solid to brittle, have a coarse to fine-crystalline structure and are translucent to opaque, but not vitreous, in color Substances above 25 ° C without decomposition, slightly liquid above the melting point (slightly viscous), have a strong temperature-dependent consistency and solubility and are polishable under light pressure.
- volatile cosmetic oil refers according to the invention cosmetic oils which at 20 ° C and an ambient pressure of 1013 hPa a vapor pressure of 2.66 Pa to 40,000 Pa (0.02 to 300 mm Hg), preferably from 10 to 12,000 Pa (0.1 to 90 mm Hg), more preferably from 13 to 3000 Pa (0.1 to 23 mm Hg), in particular from 15 to 500 Pa ( 0, 1 to 4 mm Hg).
- nonvolatile cosmetic oils in the context of the present invention means cosmetic oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.
- fatty acid as used in the present invention means aliphatic carboxylic acids which have unbranched or branched carbon residues of 4 to 40 carbon atoms also be synthetically produced fatty acids.Furthermore, the fatty acids may be monounsaturated or polyunsaturated.
- fatty alcohol in the context of the present invention means aliphatic, monohydric, primary alcohols which have unbranched or branched hydrocarbon radicals having 4 to 40 carbon atoms
- the fatty alcohols used in the context of the invention may also be monounsaturated or polyunsaturated ,
- wt .-% refers in the present case, unless otherwise stated, on the total weight of the antiperspirant cosmetic agents according to the invention without any optional propellant.
- the cosmetic oil which is liquid at 20 ° C and 1 .013 hPa is selected from the group of
- volatile cyclic silicone oils especially cyclotrisiloxane, cyclotetrasiloxane, cyclopentasiloxane and cyclohexasiloxane, and linear silicone oils having 2 to 10 siloxane units, especially hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane;
- volatile non-silicone oils especially liquid paraffin oils and isoparaffin oils such as isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan;
- nonvolatile silicone oils especially higher molecular weight linear polyalkylsiloxanes
- non-volatile non-silicone oils especially the esters of linear or branched saturated or unsaturated C 2 to C fatty acids having linear or branched saturated or unsaturated C 2 to C 30 fatty acids which may be hydroxylated, the C 8 to C 22 fatty alcohol esters more monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, the triethyl citrates, the branched saturated or unsaturated C 6 -C 30 -fatty alcohols, the mono-, di- and triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 3 -o-fatty acids, the dicarboxylic esters of linear or branched C 2 -C 10 alkanols, the Addition products of ethylene oxide and / or propylene oxide to mono- or polyhydric C3-22 alkanols, which may optionally be esterified, the symmetrical, asymmetrical or cyclic esters of carbon
- the cyclic volatile silicone oils which can be used in the context of the invention have a vapor pressure of from 13 to 15 Pa (0.1 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa. Furthermore, according to the invention as a linear volatile silicone oil and a low molecular weight phenyl trimethicone having a vapor pressure of about 2,000 Pa (15 mm Hg) at 20 ° C and an ambient pressure of 1013 hPa can be used.
- cyclic volatile silicone oils used in the antiperspirant cosmetic agents according to the invention become.
- volatile non-silicone oils in the form of ⁇ -13-isoparaffine mixtures having a vapor pressure of from 10 to 400 Pa (0.08 to 3 mm Hg), preferably from 13 to 100 Pa (0.1 to 0.8 mm Hg). , used at 20 ° C and an ambient pressure of 1 .013 hPa.
- volatile C 8 -C 16 isoparaffin it is preferred in the context of the present invention for the volatile C 8 -C 16 isoparaffin to be present in a total amount of from 1 to 60% by weight, preferably from 3 to 45% by weight, preferably from 5 to 40% by weight.
- % in particular from 8 to 20 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
- antiperspirant cosmetic products with a low proportion of volatile oils - that is, with 0.5 to 15 wt .-%, based on the total weight of the antiperspirant cosmetic agent, on volatile oils - or even without volatile oils to formulate.
- the antiperspirant cosmetic agents comprise a non-volatile silicone oil and / or a non-volatile non-silicone oil.
- preferred antiperspirant cosmetic agents contain at least one ester of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated, in a total amount of 1 to 30 wt .-%, preferably from 5 to 26 wt .-%, preferably from 9 to 24 wt .-%, in particular from 12 to 17 wt .-%, based on the total weight of the antiperspirant cosmetic agent.
- non-volatile silicone oils may be linear polyalkylsiloxanes having a kinematic viscosity of from 5 to 2,000 cSt at 25 ° C., in particular linear polydimethylsiloxanes having a kinematic viscosity at 25 ° C. of from 5 to 2,000 cSt, preferably from 10 to 350 cSt, in particular from 50 to 100 cSt.
- the non-volatile silicone oils mentioned above are available under the tradenames Dow Corning ® 200 or Xiameter PMX from Dow Corning or Xiameter.
- nonvolatile silicone oils are phenyltrimethicones having a kinematic viscosity at 25 ° C. of from 10 to 100 cSt, preferably from 15 to 30 cSt, and also cetyldimethicones.
- the cosmetic oil which is liquid at 20 ° C. and 1013 hPa is present in a total amount of from 1 to 95% by weight, preferably from 10 to 85% by weight, preferably from 20 to 75% by weight. -%, more preferably from 35 to 70 wt .-%, in particular from 50 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
- the antiperspirant compositions according to the invention less than 0.2 wt .-%, preferably less than 0.1 wt .-%, in particular 0 wt .-% of at 20 ° C and 1013 hPa containing liquid cosmetic oil.
- the use of only extremely small amounts of the cosmetic oil which is liquid at 20 ° C. and 1013 hPa is particularly preferred in the case of antiperspirant cosmetic agents according to the invention which are present in aqueous, aqueous-alcoholic or aqueous-glycolic form.
- the fragrance is selected from the group of
- esters in particular benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, lactyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate;
- DMBCA dimethylbenzylcarbinylacetate
- aldehydes especially linear alkanals of 8 to 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal;
- ketones especially ionone, alpha-isomethylionone and methyl cedryl ketone
- alcohols especially anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol;
- hydrocarbons in particular terpenes such as limonene and pinene; such as
- mixtures of different fragrances are preferably used, which together produce an appealing scent.
- Particularly pleasing antiperspirant cosmetic agents according to the invention are obtained when the perfume in a total amount of 0.00001 to 10 wt .-%, preferably from 0.001 to 9 wt .-%, preferably from 0.01 to 8 wt .-%, further preferably from 0.5 to 7 wt .-%, in particular from 1 to 6 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
- the fragrance in a total amount of 0.00001 to 5% by weight, preferably 0.001 to 4 wt .-%, preferably 0.01 to 3 wt .-%, more preferably 0 , 1 to 2 wt .-%, in particular 0.2 to 1, 5 wt .-%, based on the total weight of the blowing agent-containing antiperspirant cosmetic agent is included.
- the wax is selected from the group of
- esters of saturated, monohydric Cs -is alcohols with saturated C 12 -is monocarboxylic acids (iii) esters of saturated, monohydric Cs -is alcohols with saturated C 12 -is monocarboxylic acids;
- esters of a saturated, monohydric C 16 -C 6 alkanol and a saturated C 12 -C 36 monocarboxylic acid in particular cetyl behenate, stearyl behenate and C 20 -C 40 -alkyl stearate;
- glycerol triesters of saturated linear C 12 -C 30 carboxylic acids which may be hydroxylated, in particular hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil, glyceryl tribehenate and glyceryl tri-12-hydroxy stearate;
- animal waxes in particular beeswax, shellac wax and spermaceti;
- (ix) synthetic waxes in particular montan ester waxes, hydrogenated jojoba waxes and sasol waxes, polyalkylene waxes and polyethylene glycol waxes, C 2o-C4o dialkyl esters of dimer acids, C 30 -so-alkyl beeswax, and alkyl and alkylaryl esters of dimer fatty acids, paraffin waxes; such as
- esters of saturated, monohydric Ci2-is alcohols with saturated Ci2 -is monocarboxylic acids are stearyl laurate, cetearyl stearate (eg Crodamol® CSS), cetyl palmitate (eg Cutina® CP) and myristyl myristate (eg Cetiol® MM).
- cetearyl stearate eg Crodamol® CSS
- cetyl palmitate eg Cutina® CP
- myristyl myristate eg Cetiol® MM
- a C2o-C4o-alkyl stearate is preferably used as the wax component.
- This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc..
- the wax in a total amount of 0.01 to 20 wt .-%, preferably from 3 to 20 wt .-%, preferably from 5 to 18 wt .-%, in particular from 6 to 15 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
- a particularly good antiperspirant effect is obtained in the context of the present invention, when the antiperspirant aluminum salt in a total amount of 2 to 40% by weight, preferably from 3 to 35 wt .-%, preferably from 4 to 32 wt .-%, further preferably from 5 to 28 wt .-%, more preferably from 8 to 25 wt .-%, in particular from 12 to 22 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
- the antiperspirant aluminum salt in a total amount of 0, 1 to 20 wt .-%, preferably from 0.5 to 15 wt .-%, preferably from 1 to 12 wt .-%, more preferably from 1, 5 to 10 wt .-%, in particular from 2 to 8 wt .-%, based on the total weight of the blowing agent-containing antiperspirant composition is included.
- the antiperspirant aluminum salt may be selected from the group of
- water-soluble astringent inorganic salts of aluminum especially aluminum chlorohydrate, aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum hydroxide, potassium aluminum sulfate, aluminum bromohydrate, aluminum chloride, aluminum sulfate;
- water-soluble astringent organic salts of aluminum in particular aluminum chlorohydrex-propylene glycol, aluminum chlorohydrex-polyethylene glycol, aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-propylene glycol, aluminum sesquichlorohydrex-polyethylene glycol, aluminum-propylene glycol-dichlorhydrex, aluminum-polyethylene glycol-dichlorohydrex, aluminum undecylenoyl collagen amino acid Sodium aluminum lactate, sodium aluminum chlorhydroxactate, aluminum lipoamino acids, aluminum lactate, aluminum chlorohydroxy allantoinate, sodium aluminum chlorohydroxy lactate;
- water-soluble astringent inorganic aluminum-zirconium salts especially aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate;
- water-soluble astringent organic aluminum-zirconium salts especially aluminum zirconium-propylene glycol complexes, aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine; such as
- water-soluble aluminum salts are understood to mean those salts which have a solubility of at least 3% by weight at 20 ° C., ie at least 3 g of the antiperspirant dissolve Aluminum salt in 97 g of water at 20 ° C.
- Particularly preferred inorganic aluminum salts are chosen from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al2 (OH) 5 Cl ⁇ hbOJn 1-6, preferably [Al 2 (OH) 5 Cl ⁇ 2-3 hbOJn which (in non-activated (polymerized) or in an activated depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4Cl 2 ⁇ 1- 6 hhOJn, preferably [Al 2 (OH) 4Cl 2 ⁇ 2-3 hbOJn, in non-activated (polymerized) or in activated (depolymerized ) Form may be present.
- the preparation of such antiperspirant aluminum salts is disclosed, for example, in US 3,887,692 A, US 3,904,741 A, US 4,359,456 A, GB 2 048 229 A and GB 1 347 950 A.
- antiperspirant aluminum salts are selected from so-called “activated” aluminum salts, which are also referred to as “antiperspirant active ingredients” with enhanced activity (English: enhanced activity). Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in the publications GB 2 048 229 A, US Pat. Nos. 4,775,528 and 6,010,688.
- Activated aluminum salts are typically produced by heat-treating a dilute solution of the appropriate salt (eg, a 10 wt.% Salt solution) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for roller drying.
- Activated aluminum salts typically have an HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, especially at least 0.9, with at least 70% of the aluminum attributable to these HPLC peaks.
- activated aluminum zirconium salts which have a high HPLC peak 5 aluminum content, in particular a peak 5 area of at least 33%, preferably of at least 45%, based on the total area under the peaks 2 to 5, measured by HPLC of a 10% by weight aqueous solution of the active ingredient under conditions in which the aluminum species are resolved into at least 4 successive peaks (denoted peaks 2 to 5)
- Preferred aluminum-zirconium salts of high HPLC peak 5-aluminum content (also referred to as "E 5 AZCH”) is disclosed, for example, in US 6 436 381 A and US 6 649 152 A.
- the abovementioned activated aluminum-zirconium salt may additionally be treated with a water-soluble strontium salt and / or stabilized with a water-soluble calcium salt, as disclosed, for example, in US Pat. No. 6,923,952 A.
- antiperspirant aluminum salts as nonaqueous solutions or solubilisates of an activated antiperspirant aluminum or aluminum zirconium salt, for example in accordance with US Pat. No. 6,010,688 A.
- Such aluminum or aluminum zirconium salts are stabilized by the addition of an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, against the loss of activation of the salt.
- complexes of activated aluminum or aluminum-zirconium antiperspirant salts with a polyhydric alcohol containing from 20 to 50% by weight, preferably from 20 to 42% by weight, activated antiperspirant aluminum or aluminum zirconium salt and from 2 to 16 Wt .-% molecularly bound water, the remainder to 100 wt .-% is at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups.
- Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
- Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. For example, in documents US 5,643,558 A and US 6,245,325.
- antiperspirant aluminum salts of basic calcium aluminum salts as z.
- these salts can be prepared by reaction of calcium carbonate with aluminum chlorohydrate or aluminum chloride and aluminum powder or by adding Calcium chloride dihydrate are obtained to aluminum chlorhydroxide.
- aluminum-zirconium complexes which are buffered with salts of amino acids, in particular with alkali and Erdalkaliglycinaten, and as such.
- use As disclosed in the document US 4 017 599 A, use.
- activated aluminum salts are those of the general formula Al 2 (OH) 6- a Xa, where X is Cl, Br, I or NO 3 and "a" is a number from 0.3 to 5, preferably from 0.8 to 2, 5 is in particular from 1 to 2, so that the molar ratio of Al: X 0.9: 1 to 2, 1: 1.
- Such activated antiperspirant aluminum salts are disclosed, for example, in US Pat. No. 6,074,632.
- Preferred activated aluminum-zirconium salts are those of the general formula ZrO (OH) 2-P BYB, wherein Y is Cl, Br, I, NO3 or SO4, b is a rational number from 0.8 to 2 and p is the valence of Y is such that the Al: Zr molar ratio is from 2 to 10 and the metal: (X + Y) ratio is from 0.73 to 1.2, preferably from 0.9 to 1.5.
- Such activated antiperspirant aluminum zirconium salts are disclosed, for example, in the aforementioned US Pat. No. 6,074,632.
- a particularly preferred salt is aluminum-zirconium chlorohydrate (i.e., X and Y are Cl), which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
- Preferred antiperspirant active compounds are disclosed in US 6,663,854 A and US 2004/0009133 A1.
- Particularly preferred antiperspirant aluminum salts according to the invention have a molar metal-to-chloride ratio of 1.9 to 1.2.
- the metal-to-chloride ratio of aluminum sesquichlorohydrates which is also particularly preferred in the invention is from 1.5: 1 to 1.8: 1.
- Preferred aluminum-zirconium tetrachlorohydrates have a molar ratio of Al: Zr of from 2 to 6 and of metal: chloride of from 0.9 to 1 .3, in particular salts having a molar metal-to-chloride ratio of from 0.9 to 1.1 , preferably from 0.9 to 1.0 are preferred.
- a particularly high activity and significantly improved stabilization of the antiperspirant aluminum salt is achieved if the alpha-hydroxy acid is used in a total amount of from 0.05 to 8% by weight, preferably from 0.1 to 7% by weight. , preferably from 0.3 to 5 wt .-%, more preferably from 0.5 to 3 wt .-%, still more preferably from 0.8 to 2.5 wt .-%, in particular from 1 to 2 wt. %, based on the total weight of the antiperspirant cosmetic agent.
- the antiperspirant cosmetic agents may contain the alpha-hydroxy acid in a total amount of 0.05 to 20% by weight, preferably 0.3 to 18% by weight, preferably 0.5 to 15 Wt .-%, more preferably from 0.7 to 10 wt .-%, even more preferably from 1, 0 to 9 wt .-%, in particular from 1, 5 to 6 wt .-%, based on the total weight of the blowing agent-containing antiperspirant cosmetic agent.
- the use of the abovementioned amount (s) of the alpha-hydroxy acid (s) results in a significantly increased formation of short-chain polymers of the antiperspirant aluminum salt and thus in an improved antiperspirant effect.
- the short-chain polymers of the antiperspirant aluminum salt are effectively stabilized over a long period of time, so that the use of the alpha-hydroxy acid in the amounts listed above results in a significantly improved antiperspirant effect even after prolonged storage.
- the antiperspirant cosmetic agent contains at least one alpha-hydroxy acid of -la) and / or (HS-1b) and / or (HS-1c) and / or (HS-ld ) and / or (HS-le)
- Y + stands for Li + , Na + , 7 2 Mg 2+ , 7 2 Ca 2+ , 7 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , 7 Zr 4 * or at least one antiperspirant aluminum salt,
- X + for H + Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V Zr 4 * or at least one antiperspirant aluminum salt, and
- Z + for Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V Zr 4 * or at least one antiperspirant aluminum salt is, contains.
- the antiperspirant effect of the antiperspirant cosmetic agents of the present invention can be further improved if the antiperspirant cosmetic agent has a weight ratio of the antiperspirant aluminum salt to the alpha-hydroxy acid of 40: 1 to 19: 1, preferably 30: 1 to 16: 1, preferably 20: From 1 to 15: 1, more preferably from 10: 1 to 13: 1, even more preferably from 9: 1 to 12: 1, in particular from 8: 1 to 1: 1.
- the above-mentioned weight ratio refers to the total amount of all antiperspirant aluminum salts and the total amount of all alpha-hydroxy acids in the antiperspirant cosmetic agent.
- the weight ratio of the antiperspirant aluminum salt to the alpha-hydroxy acid is 5: 1.
- the use of a weight ratio of the antiperspirant aluminum salt to the alpha-hydroxy acid of 10: 1 leads to antiperspirant cosmetic agents according to the invention, which are excellent Have antiperspirant activity and no significant deterioration of the antiperspirant effect occurs even after long storage periods.
- protic solvents in particular in high concentrations or amounts, can be used without the antiperspirant effect of the antiperspirant cosmetic agents according to the invention being adversely affected, so that an extremely flexible formulation of the compositions according to the invention is possible.
- the antiperspirant cosmetic agent contains no zirconium-containing compounds.
- the inventive avoidance of the use of zirconium-containing antiperspirant compounds, such as zirconium-aluminum mixed salts results in the cost-effective provision of the antiperspirant cosmetic agents of the invention, since the raw materials for the production of zirconium-containing compounds have higher prices.
- the antiperspirant cosmetic agent preferably contains free water in a total amount of less than 10% by weight, preferably less than 8% by weight, preferably less than 5% by weight, more preferably less than 3% by weight. even more preferably less than 1% by weight, in particular 0% by weight, based on the total weight of the antiperspirant cosmetic agent.
- free water is thus understood to mean water which is different from water of crystallization, water of hydration or similar molecularly bound water of the constituents used, in particular the antiperspirant aluminum salts.
- the antiperspirant cosmetic agent therefore contains free water in a total amount of 15 to 96 wt .-%, preferably from 25 to 80 wt .-%, preferably from 30 to 70 wt .-%, in particular of 40 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent.
- the antiperspirant cosmetic agents according to the invention are preferably in the form of a suspension of the undissolved antiperspirant aluminum salt in the cosmetic oil which is liquid at 20 ° C. and 1 .013 hPa.
- the antiperspirant cosmetic agent is present as a water-in-oil emulsion.
- This may in particular be a sprayable water-in-oil emulsion which can be sprayed by means of a propellant.
- the present invention in the form of a water-in-oil emulsion antiperspirant cosmetic agent, the alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably from 0.1 to 7 wt %, preferably from 0.3 to 5% by weight, more preferably from 0.5 to 3% by weight, still more preferably from 0.8 to 2.5% by weight, most preferably from 1 to 2 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.
- the antiperspirant cosmetic agent is present as an oil-in-water emulsion.
- the agent according to the invention is preferably sprayed as a propellant-free pump spray or squish spray or applied as a roll-on.
- the present in the form of an oil-in-water emulsion antiperspirant cosmetic agent the alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably from 0.1 to 7 wt.
- % preferably from 0.3 to 5% by weight, more preferably from 0.5 to 3% by weight, even more preferably from 0.8 to 2.5% by weight, in particular from 1 to 2 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.
- the antiperspirant cosmetic agent is present as an aqueous, aqueous-alcoholic or aqueous-glycolic solution.
- a sweat-inhibiting aluminum salt with an alpha-hydroxy acid even in protic solvents, such as aqueous solutions, high amounts of activated aluminum salt can be formed or stabilized, so that according to the invention the use of aqueous antiperspirant cosmetic agents is also possible without a Deactivation of the antiperspirant aluminum salts and thus a significant reduction in the antiperspirant effect occurs.
- the antiperspirant cosmetic agent contains ethanol in a total amount of 1 to 50 wt .-%, preferably from 5 to 40 wt .-%, preferably from 7 to 35 wt .-%, in particular from 10 to 30 Wt .-%, based on the total weight of the antiperspirant cosmetic agent.
- the antiperspirant cosmetic agent ethanol in a total amount of 10 to 95 wt .-%, preferably from 15 to 90 wt .-%, preferably from 20 to 87 wt .-%, more preferably from 30 to 85 wt .-%, in particular from 40 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.
- the use of the alpha-hydroxy acid itself can utilize high levels of protic solvents, such as ethanol, without adversely affecting the activation or stabilization of the short-chain polymers of the antiperspirant aluminum salt.
- the antiperspirant cosmetic agent is formulated as a spray application.
- the spray application is carried out with a spray device which contains a filling of the liquid, viscous-flowable, suspension-shaped or powdered antiperspirant cosmetic agent according to the invention in a container.
- the filling may be under the pressure of a propellant (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer without propellant (pump sprays / squeeze bottle).
- the containers have a removal device, preferably in the form of valves, which allow the removal of the contents as a mist, smoke, foam, powder, paste or liquid jet.
- containers for the spray devices are mainly cylindrical vessels made of metal (aluminum, tinplate, volume preferably a maximum of 1,000 ml), protected or non-splitterndem glass or plastic (volume preferably a maximum of 220 ml) or splintering glass or plastic (volume preferably 50th to 400 ml) in question.
- Creamy, gelatinous, pasty and liquid agents may be packaged, for example, in pump, spray or squeeze dispensers, in particular in multi-chamber pumping, multi-chamber spray or multi-chamber squeeze dispensers.
- the Packaging for the compositions according to the invention may be opaque, but also transparent or translucent.
- the antiperspirant cosmetic is preferably formulated as a stick, soft solid, cream, roll-on, dibenzylidenalditol-based gel, loose or compact powder.
- the formulation of the antiperspirant cosmetic agents according to the invention in a particular dosage form such as, for example, an antiperspirant roll-on, an antiperspirant stick or an antiperspirant gel, preferably conforms to the requirements of the intended use.
- the antiperspirant cosmetic agents according to the invention can therefore be present in solid, semisolid, liquid, disperse, emulsified, suspended, gelatinous, multiphase or powdery form.
- the term liquid also includes any types of solid dispersions in liquids.
- multiphase antiperspirant cosmetic agents are also understood to mean agents which have at least two different phases with a phase separation and in which the phases can be arranged horizontally, ie one above the other, or vertically, ie side by side.
- the application can be done, for example, with a roller ball applicator.
- Such scooters have a ball mounted in a ball bed which can be moved by movement over a surface. The ball picks up some of the sweat-inhibiting agent to be distributed and conveys it to the surface to be treated.
- the packaging for the compositions according to the invention can, as stated above, be opaque, transparent or translucent.
- the antiperspirant cosmetic agent is contained on and / or in a disposable substrate selected from the group of wipes, pads and bulbs.
- a disposable substrate selected from the group of wipes, pads and bulbs.
- wet wipes ie prefabricated for the user, preferably individually packaged, wet wipes, as they are for. B. from the field of glass cleaning or from the field of wet toilet paper are well known.
- Such wet wipes which can advantageously also contain preservatives, are impregnated or applied with an antiperspirant cosmetic agent according to the invention and preferably individually packaged. You can z. B. be used as a deodorant cloth, which is particularly interesting for use on the go.
- Preferred substrate materials are selected from porous sheet-like cloths.
- wipes can be made of a fibrous or cellular flexible material which has sufficient mechanical stability and softness for application to the skin.
- wipes include wipes made of woven and nonwoven (nonwoven) synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.
- Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a perspiration-inhibiting cosmetic agent according to the invention onto a substrate.
- the antiperspirant cosmetic agents of the present invention may further contain other adjuvants.
- the antiperspirant cosmetic agents according to the invention preferably contain at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) hydrogel formers; (iii) chelating agents; (iv) deodorant agents; (v) monohydric and / or polyhydric alcohols and / or polyethylene glycols; (vi) skin-cooling agents; (vii) propellants; (viii) thickeners and (ix) their mixtures.
- Emulsifiers and surfactants which are preferably suitable according to the invention are selected from anionic, cationic, nonionic, amphoteric, in particular ampholytic and zwitterionic emulsifiers and surfactants.
- Surfactants are amphiphilic (bifunctional) compounds which consist of at least one hydrophobic and at least one hydrophilic moiety.
- the hydrophobic moiety is preferably a hydrocarbon chain of 8 to 28 carbon atoms, which may be saturated or unsaturated, linear or branched. Most preferably, this C8-C28 alkyl chain is linear.
- anionic surfactants surfactants with exclusively anionic charges; they contain z.
- carboxyl groups sulfonic acid groups or sulfate groups.
- Particularly preferred anionic surfactants are alkyl sulfates, alkyl ether sulfates, acyl glutamates and Cs-24 carboxylic acids and their salts, the so-called soaps.
- Cationic surfactants are understood as meaning surfactants with exclusively cationic charges; they contain z.
- Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
- amphoteric surfactants are subdivided into ampholytic surfactants and zwitterionic surfactants.
- Ampholytic surfactants are understood as meaning those surface-active compounds which have both acidic (for example -COOH or -SO 3 H groups) and basic hydrophilic groups (for example amino groups) and thus behave acidic or basic depending on the condition.
- Zwitterionic surfactants are understood by the person skilled in the art to be surfactants which carry both a negative and a positive charge in the same molecule.
- Zwitterionic surfactants are the betaines, the N-alkyl-N, N-dimethylammonium glycinates, the N-acyl-aminopropyl-N, N-dimethylammoniumglycinate and the 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazoline with 8 to 24 carbon atoms in the alkyl group.
- ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having 8 to 24 Carbon atoms in the alkyl group
- compositions according to the invention which are formulated as an emulsion, in particular as an oil-in-water emulsion, preferably comprise at least one nonionic oil-in-water emulsifier having an HLB value of more than 7 to 20.
- nonionic oil-in-water emulsifier having an HLB value of more than 7 to 20.
- L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.
- a water-in-oil emulsifier having an HLB value of greater than 1.0 and less than or equal to 7.0 is used.
- Nonionic oil-in-water emulsifiers suitable for the purposes of the present invention and suitable nonionic water-in-oil emulsifiers are described, for example, in German Offenlegungsschrift DE 10 2006 004 957 A1.
- hydrogel-forming substances which are selected from cellulose ethers, especially hydroxyalkylcelluloses, in particular hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cetylhydroxyethylcellulose, hydroxybutylmethylcellulose, methylhydroxyethylcellulose, furthermore xanthan gum, sclerotium gum , Succinoglucans, polygalactomannans, in particular guar gums and locust bean gum, in particular guar gum and locust bean gum itself and the nonionic hydroxyalkyl guar derivatives and locust bean gum derivatives, such as hydroxypropyl guar, carboxymethylhydroxypropyl guar, hydroxypropylmethyl guar, hydroxyethyl guar and Carboxymethylguar, pectins, agar, carrageenan, tragacanth, gum arabic
- hydrogel formers are selected from cellulose ethers, in particular from hydroxyalkylcelluloses, in particular from hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cetylhydroxyethylcellulose, hydroxybutylmethylcellulose and methylhydroxyethylcellulose, and mixtures thereof. Hydroxyethyl cellulose is preferably used as hydrogel former.
- At least one chelating agent according to the invention selected from ethylenediaminetetraacetic acid (EDTA) and its salts and nitrilotriacetic acid (NTA) and mixtures thereof Substances, in a total amount of 0.01 to 0.5 wt .-%, preferably from 0.02 to 0.3 wt .-%, in particular from 0.05 to 0.1% by weight, based on the total weight of the antiperspirant agent according to the invention.
- chelating agents which are selected from the group consisting of ⁇ -alaninediacetic acid, cyclodextrin, diethylenetriaminepentamethylenephosphonic acid, sodium, potassium, calcium disodium, ammonium and triethanolamine salts of ethylenediaminetetraacetic acid (EDTA), etidronic acid, hydroxyethylethylenediaminetetraacetic acid (HEDTA) and their sodium salts, sodium salts of nitrilotriacetic acid (NTA), diethylenetriaminepentaacetic acid, phytic acid,
- Tetrasodiumiminodisuccinate Tetrasodiumiminodisuccinate, trisodium ethylenediamine disuccinate and desferrioxamine.
- the antiperspirant effect of the antiperspirant cosmetic agents according to the invention can be further increased if at least one deodorant active ingredient in a total amount of 0.0001 to 40 wt .-%, preferably from 0.2 to 20 wt .-%, preferably from 1 to 15 wt .-%, in particular from 1, 5 to 5 wt .-%, based on the total weight of the antiperspirant cosmetic agent according to the invention, is included. If ethanol is used in the compositions according to the invention, this does not apply in the context of the present invention as a deodorant active ingredient, but as a constituent of the carrier.
- Deodorant agents which are preferred according to the invention are selected from the group of (i) silver salts; (ii) aromatic alcohols, in particular 2-benzylheptan-1-ol and mixtures of 2-benzylheptan-1-ol and phenoxyethanol; (iii) 1,2-alkanediols having 5 to 12 carbon atoms, especially 3- (2-ethylhexyloxy) -1, 2-propanediol; (iv) triethyl citrate; (v) agents against exoesterases, especially against arylsulfatase, lipase, beta-glucuronidase and cystathion-beta-lyase; (vi) cationic phospholipids; (vii) odor absorbers, in particular silicates, such as montmorillonite, kaolinite, IIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and tal
- Preferred antiperspirant cosmetic agents according to the invention also contain at least one water-soluble polyhydric C 2-9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 50 ethylene oxide units and mixtures thereof. This does not include the abovementioned deodorant active ingredients in the form of 1, 2-alkanediols.
- Preferred alkanols are selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, and pentylene glycols, such as 1,2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 2-hexanediol and 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol , Erythritol, sorbitol, cis-1,4-dimethylolcyclohexane, trans-1,4-dimethylolcyclohexane, any mixture
- Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
- the antiperspirant cosmetic agents further contain at least one skin-cooling agent.
- Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl ethyl oxamate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxy propane diol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), mono-menthyl succinate, 2-hydroxymethyl -3,5,5-trimethylcyclohexanol and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate.
- Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol, menthylpyrrolidonecarboxylic acid and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate, as well as mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
- the antiperspirant cosmetic agents according to the invention contain a propellant.
- propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane, tetrafluoropropenes, both individually and in their mixtures.
- hydrophilic propellants such as carbon dioxide
- hydrophilic propellants such as carbon dioxide
- lipophilic propellant gas eg., Propane / butane
- propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
- the total amount of the blowing agent is 20 to 95 wt.%, Preferably 30 to 85 wt.%, In particular 40 to 75 wt .-%, each based on the total weight of Antiperspirants, consisting of the antiperspirant cosmetic agent according to the invention and the propellant.
- the total amount of blowing agent 1 to 95 wt .-%, preferably 2 to 85 wt .-%, in particular 3 to 75 wt .-%, .-%, each based on the total weight of Antiperspirant, consisting of the antiperspirant cosmetic agent of the invention and the propellant is.
- lipophilic thickeners can furthermore be used according to the invention.
- the at least one antiperspirant aluminum salt is suspended undissolved in at least one at 20 ° C and 1013 hPa liquid cosmetic oil.
- at least one lipophilic thickener may be added to this suspension as a suspending aid.
- Lipophilic thickeners preferred according to the invention are selected from hydrophobized clay minerals and fumed silicic acids.
- the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as a water-in-oil emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt.
- wt .-% preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-% , at least one alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 Wt .-%, even more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 12 to 90 wt .-%, preferably 25 to 55 wt .-%, preferably 30 to 50 Wt .-%, in particular 35 to 45 wt .-% water,
- the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
- % at least one alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, still more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, From 15 to 90% by weight, preferably from 25 to 55% by weight, preferably from 30 to 50% by weight, in particular from 35 to 45% by weight, of water,
- a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one alpha-hydroxy acid in a total amount of a total of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, still more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 90 wt .-%, preferably 25
- a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one alpha-hydroxy acid in a total amount of a total of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, still more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 90 wt .-%, preferably 25
- the antiperspirant cosmetic agents according to the invention have a dynamic viscosity in the range from 10 to 5000 mPas, preferably from 100 to 1000 mPas, preferably from 200 to 800 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s ⁇ without Helipath, at 20 ° C ambient temperature and 20 ° C sample temperature.
- a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one alpha-hydroxy acid in a total amount of a total of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, still more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 90 wt .-%, preferably 25
- the antiperspirant cosmetic agents according to the invention have a dynamic viscosity in the range from 1000 to 800,000 mPas, preferably from 2,000 to 700,000 mPas, preferably from 3,000 to 500,000 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s 1 , without helipath, at 20 ° C ambient temperature and 20 ° C sample temperature.
- the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as a water-in-oil emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
- % at least one alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, still more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 75 wt .-%, preferably 25 to 60 wt .-%, preferably 30 to 55 wt .-%, in particular 35 to 50 wt .-% water
- the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
- % at least one alpha-hydroxy acid in a total amount of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 90 wt .-%, preferably 25 to 80 wt .-%, preferably 30 to 75 wt .-%, in particular 40 to 60 Gew. -% water, and
- wt .-% optionally 0.01 to 2 wt .-%, preferably 0, 1 to 1 wt .-%, preferably 0.2 to 0.7 wt .-%, in particular 0.3 to 0.5 wt .-% of a hydrogel containing forming substance.
- a second object of the present invention is the use of a combination of at least one selected from the group of cosmetic oils which are liquid at 20 ° C and 1 .013 hPa, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of 1 to 80 wt .-%, based on the total weight of the combination, and at least one alpha-hydroxy acid of the formula (HS-I), (HS-II) and (HS-III)
- R is a linear or branched alkyl group having 1 to 6 carbon atoms
- R 2 , R 3 , R 4 and R 5 each independently represent hydrogen, -OH, a linear or branched alkyl group of 1 to 8 carbon atoms, an alkoxy group of 1 to 6
- R 7 , R 8 , R 9 and R 0 each independently of one another, represent hydrogen, an alkoxy group having 1 to 6 carbon atoms or -OH,
- y is a number from 0 to 5
- X + for H + Li + , Na + , K + , NH 4 + , 7 2 Mg 2+ , 7 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 "or at least one antiperspirant aluminum salt, and
- Y + is Li + , Na + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 "or at least one antiperspirant aluminum salt .
- X + is Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , 4 Zr 4 * or at least one antiperspirant aluminum salt when R 4 is a galactopyranose residue,
- a third aspect of the present invention is a non-therapeutic cosmetic method for preventing and / or reducing transpiration of the body, which comprises an antiperspirant cosmetic agent containing at least one selected from the group of cosmetic oils at 20 ° C and 1,013 hPa liquid, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of 1 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent, and at least one alpha-hydroxy acid, on the skin, in particular on the skin the armpits, is applied.
- an antiperspirant cosmetic agent containing at least one selected from the group of cosmetic oils at 20 ° C and 1,013 hPa liquid, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of 1 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent, and at least one alpha-hydroxy acid, on the skin, in particular on the skin the armpits, is applied.
- a fourth subject of the present invention is the use of at least one alpha-hydroxy acid selected from one of the formulas (HS-I), (HS-II) and (HS-III)
- R is a linear or branched alkyl group having 1 to 6 carbon atoms
- R 7 , R 8 , R 9 and R 0 each independently of one another, represent hydrogen, an alkoxy group having 1 to 6 carbon atoms or -OH,
- y is a number from 0 to 5
- X + for H + Li + , Na + , K + , NH 4 + , 7 2 Mg 2+ , 7 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , 7 Zr 4 * or at least one antiperspirant aluminum salt, and
- Y + is Li + , Na + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V Zr 4 * or at least one antiperspirant aluminum salt,
- X + is Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V Zr 4 * or at least one antiperspirant aluminum salt if R 4 is a galactopyranose residue,
- Activation in the context of the present invention means the significantly increased formation of short-chain polymers of the antiperspirant aluminum salt when using alpha-hydroxy acid (s).
- Stabilization in the context of the present invention furthermore refers to the avoidance or significant slowing down of the reformation of high-chain polymers from the short-chain polymers of the antiperspirant aluminum salts formed during the activation.
- alpha-hydroxy acids By using special alpha-hydroxy acids, it has surprisingly been possible to significantly increase the activity of antiperspirant aluminum salts even over a longer storage period. Without wishing to be limited by this theory, the use of alpha-hydroxy acid (s) achieves a significant increase in the proportion of short-chain species of the antiperspirant aluminum salts. Furthermore, the thus formed short-chain species are excellently stabilized by the aforementioned alpha-hydroxy acids, so that an improved antiperspirant effect is ensured over a long period of time.
- a particularly good activation and / or stabilization of the at least one antiperspirant aluminum salt is achieved if the alpha-hydroxy acid in a total amount of 0.01 to 50 wt .-%, preferably from 0, 1 to 40 wt .-%, preferably from 0 , 5 to 30 wt .-%, more preferably from 1 to 20 wt .-%, even more preferably from 1, 5 to 10% by weight, in particular from 2 to 7 wt .-%, based on the total weight of the Compound of the alpha-hydroxy acid, the at least one antiperspirant aluminum salt and optionally other ingredients is used.
- the abovementioned amounts lead to a particularly good activation and stabilization of the antiperspirant aluminum salt even over longer storage periods.
- the antiperspirant aluminum salt in a total amount of 1 to 99.99 wt .-%, preferably from 2 to 80 wt .-%, preferably from 3 to 60 wt .-%, more preferably from 4 to 50 wt .-%, in particular from 6 to 45 wt .-%, based on the total weight of the alpha-hydroxy acid, the at least one antiperspirant aluminum salt and optionally further ingredients is used.
- a weight ratio of the antiperspirant aluminum salt to the alpha-hydroxy acid of 5,000: 1 to 1: 0.16, preferably from 1000: 1 to 1: 1, preferably from 100: 1 to 1: 5, more preferably from 50: 1 to 1:10, even more preferably from 10: 1 to 1:30, in particular from 4: 1 to 1: 50, is used.
- the above-mentioned weight ratio refers to the total amount of all antiperspirant aluminum salts and all alpha-hydroxy acids in the antiperspirant cosmetic agent.
- a total amount of free water is from 1 to 90% by weight, preferably from 5 to 80% by weight, preferably from 10 to 70% by weight, more preferably from 12 to 60% by weight. , in particular from 15 to 55 wt .-%, based on the total weight of the alpha-hydroxy acid, the at least one antiperspirant aluminum salt, the free water and optionally other ingredients is used.
- the liquid mixture resulting from the activation and stabilization of the at least one antiperspirant aluminum salt by the alpha-hydroxy acid ⁇ can be carried out, for example, by means of conventional drying methods, such as spray drying.
- the powders obtained in this way are excellent storage and have a long shelf life.
- aqueous solutions are prepared and stored for 4 weeks at room temperature (in% by weight):
- Such solutions are, inter alia, representative of hydrous antiperspirant emulsions (antiperspirant rollons, antiperspirant sticks, antiperspirant gels, antiperspirant pump sprayers).
- the activation which results directly from the polymer distribution of the samples VI, E1 and E-II, is determined by size exclusion chromatography (also called “size exclusion chromatography" or SEC.)
- size exclusion chromatography also called “size exclusion chromatography” or SEC.
- SEC size exclusion chromatography
- the respective sample is first adjusted to the concentration of 1 g ACH / 25 ml of water and filtered (0.2 ⁇ filter) .
- the respective sample is then measured using SEC using a commercial HPLC equipment with a refractive index detector, using the following parameters:
- peaks are obtained, with the lower retention time peaks for the ACH long chain polymers, and the higher retention time peaks for shorter chain length ACH polymers.
- the peaks obtained for each sample in the chromatogram are integrated, with peaks 2 and 3 (long chain polymers), 4 to 8 (medium chain polymers), 9 to 1 1 (short chain polymers) and 12, and all subsequent peaks (very high) short chain length of the polymers) due to shoulders are integrated together.
- the following table shows the area proportions of the peak groups 1, 2 to 3, 4 to 8, 9 to 1 1 and 12 and more in relation to the total area of the peaks obtained for the respective sample in the chromatogram:
- E-Il 6 25 41 23 4 The formulations according to the invention El and E-Il have a significantly higher proportion of short-chain polymers (peaks 9 to 12 or more), ie, a significantly better activation and stabilization, than the Comparative Example VI. Consequently, the use of gluconic acid and glucone-5-lactone results in significantly improved activation and stabilization of the aluminum salt used.
- the following formulation examples are intended to illustrate the subject matter of the invention without limiting it thereto.
- the compounds of the formulas (HS-1), (HS-II) and / or (HS-III) used in the following examples are preferably salts of lactic acid (formula HS-1a), glucaric acid or salts thereof (formula HS-IIa ), Gluconic acid or its salts (formula HS-IIb), salts of lactobionic acid (formula HS-IIc), glucone-5-lactone (formula HS-I IIa) and mixtures thereof.
- the compound of the formulas (HS-I) used in the following examples is preferably glycolic acid and salts thereof:
- Antiperspirant cosmetic agents according to the invention (amounts in% by weight)
- Cyclomethicone (at least 95% by weight cyclopentad ad ad ad siloxane) 100 100 100 100 100 100 100 100 100 100 100 100 Antiperspirant cosmetic agents according to the invention in the form of an oil-in-water emulsion (amounts in% by weight)
- Antiperspirant cosmetic agents according to the invention in the form of microemulsions (in% by weight)
- a single-layer substrate of 100% viscose having a weight per unit area of 50 g / m 2 was applied to 75 g each of the exemplary emulsions 14 or 15 per square meter or 75 g each of the exemplary compositions 10 and 11, respectively , cut into cloths of suitable size and packed in sachets.
- Antiperspirant cosmetic agents according to the invention in the form of a water-in-oil emulsion (amounts in% by weight)
- Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
- Example compositions 27-30 were filled into an aluminum epoxy spray can optionally coated with epoxy-phenolic lacquer in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
- propellant butane / propane / isobutane mixture
- Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
- Example compositions 31-33 were placed in an optionally epoxy-phenolic varnish-sprayed aluminum spray can at a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40 and 90, respectively : 10 bottled.
- propellant butane / propane / isobutane mixture
- Antiperspirant cosmetic agents according to the invention in the form of O / W emulsions (amounts in parts by weight)
- Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
- Example compositions 37-40 were placed in an optionally epoxy-phenolic lacquer sprayed aluminum spray can at a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40, and 90, respectively : 10 bottled.
- propellant butane / propane / isobutane mixture
- Antiperspirant cosmetic compositions according to the invention in the form of W / O emulsions (amounts in% by weight)
- Plantar ® 2000 DECYL GLUCOSIDE about 50% AS BASF
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne un produit cosmétique anti-transpirant, contenant a) au moins une substance choisie dans le groupe constitué par les huiles cosmétiques qui sont à l'état liquide à une température de 20 °C et sous une pression de 1 013 h Pa, les parfums et les cires, b) au moins un sel d'aluminium anti-transpirant en quantité totale de 1 à 80 % en poids, rapportée au poids total du produit cosmétique anti-transpirant, et c) au moins un alpha-hydroxyacide particulier, l'ajout dudit au moins un alpha-hydroxyacide ayant pour conséquence une activation efficace dudit au moins un sel d'aluminium anti-transpirant et une excellente stabilisation de cet état activé.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201310220777 DE102013220777A1 (de) | 2013-10-15 | 2013-10-15 | Schweißhemmende kosmetische Mittel mit alpha-Hydroxysäuren |
| PCT/DE2014/200516 WO2015055199A2 (fr) | 2013-10-15 | 2014-09-26 | Produits cosmétiques anti-transpirants aux alpha-hydroxyacides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3057567A2 true EP3057567A2 (fr) | 2016-08-24 |
Family
ID=51897035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14796688.1A Withdrawn EP3057567A2 (fr) | 2013-10-15 | 2014-09-26 | Produits cosmétiques anti-transpirants aux alpha-hydroxyacides |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20160206529A1 (fr) |
| EP (1) | EP3057567A2 (fr) |
| DE (1) | DE102013220777A1 (fr) |
| WO (1) | WO2015055199A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016000190A1 (de) | 2015-07-21 | 2017-01-26 | Beiersdorf Ag | Kosmetische Zubereitung enthaltend Polyquaternium-6 und/oder Polyquaternium-16 |
| US20240325272A1 (en) * | 2023-03-31 | 2024-10-03 | Colgate-Palmolive Company | Personal care compositions |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2734847A (en) * | 1956-02-14 | Ptoatw | ||
| US2571030A (en) | 1950-03-15 | 1951-10-09 | Reheis Company Inc | Astringent, antiperspirant, and method of making |
| US3542919A (en) | 1956-06-04 | 1970-11-24 | Wickhen Products Inc | Astringent alkali metal aluminum complexes of hydroxy acids |
| GB1054265A (fr) | 1962-11-07 | 1900-01-01 | ||
| US3904741A (en) | 1970-10-26 | 1975-09-09 | Armour Pharma | Alcohol soluble basic aluminum chlorides and method of making same |
| CA958338A (en) | 1971-03-08 | 1974-11-26 | Chung T. Shin | Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation |
| US3887692A (en) | 1972-07-10 | 1975-06-03 | Armour Pharma | Microspherical basic aluminum halides and method of making same |
| US3991176A (en) | 1973-11-23 | 1976-11-09 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with hydroxy carboxylic compounds |
| US4017599A (en) | 1973-11-23 | 1977-04-12 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with salts of amino acids |
| US4359456A (en) | 1976-01-14 | 1982-11-16 | Lever Brothers Company | Antiperspirant activity of basic aluminum compounds |
| GB2048229A (en) | 1979-04-20 | 1980-12-10 | Gillette Co | Aluminium Chlorhydroxide and Preparation Thereof |
| US4775528A (en) | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
| IL77011A (en) | 1984-11-21 | 1988-12-30 | Armour Pharma | Aluminum chlorhydrates,antiperspirant compositions containing the same and methods for the preparation thereof |
| GB8503672D0 (en) | 1985-02-13 | 1985-03-13 | Unilever Plc | Basic aluminium halides |
| DK483587D0 (da) * | 1987-09-15 | 1987-09-15 | Riemann & Co Aps Claus | Antiperspirant praeparat |
| US4818512A (en) | 1987-09-23 | 1989-04-04 | Bristol-Myers Company | Activated aluminum chlorhydroxide |
| US5643558A (en) | 1994-11-02 | 1997-07-01 | The Gillette Company | Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives |
| US6010688A (en) | 1997-06-25 | 2000-01-04 | The Gillette Company | Polyhydric alcohol stabilized antiperspirant salt solutions |
| US6042816A (en) | 1998-08-19 | 2000-03-28 | The Gillette Company | Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts |
| EP1280503A2 (fr) * | 2000-05-12 | 2003-02-05 | Unilever Plc | Compositions antitranspirantes et/ou deodorantes |
| US6436381B1 (en) | 2000-10-25 | 2002-08-20 | The Gillette Company | Aluminum-zirconium antiperspirant salts with high peak 5 al content |
| DE10111250A1 (de) * | 2001-03-09 | 2002-09-12 | Henkel Kgaa | Transparente Antitranspirant-Zusammensetzung |
| US6726901B2 (en) * | 2002-05-09 | 2004-04-27 | The Gillette Company | Stabilized antiperspirant compositions containing aluminum-zirconium salts with low M:Cl ratio |
| US6663854B1 (en) | 2002-06-19 | 2003-12-16 | Yan-Fei Shen | Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio |
| US6835373B2 (en) | 2002-07-12 | 2004-12-28 | The Procter & Gamble Company | Non-irritating antiperspirant compositions containing acidic antiperspirant active |
| US7105691B2 (en) | 2003-06-26 | 2006-09-12 | Colgate-Palmolive Company | Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine |
| US6923952B2 (en) | 2003-08-14 | 2005-08-02 | The Gillette Company | Enhanced efficacy antiperspirant compositions containing strontium or calcium |
| DE102004032734A1 (de) * | 2004-03-18 | 2005-10-06 | Henkel Kgaa | Präbiotisch wirksame Substanzen für Deodorantien |
| DE102004015025A1 (de) | 2004-03-26 | 2005-10-13 | Clariant Gmbh | Basische Aluminiumhalogenid-Komplexe |
| DE102006004957A1 (de) | 2006-02-01 | 2007-08-02 | Henkel Kgaa | Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion/Emulsion |
| CL2006003116A1 (es) * | 2005-11-16 | 2008-02-29 | Colgate Palmolive Co | Composicion antitranspirante que comprende al menos una sal elegida de aluminio, aluminio zirconio, una sal compleja de aluminio o una sal compleja de aluminio-zirconio, un hidroxiacido y un compuesto acido de amonio cuaternario; proceso para prepara |
| MX2008008488A (es) * | 2005-12-29 | 2008-11-27 | Riemann Trading Aps | Emulsion de tipo alcohol en aceite que comprende una sal de metal. |
| DE102010055816A1 (de) * | 2010-12-23 | 2012-06-28 | Henkel Ag & Co. Kgaa | Deodorant- und Antitranspirant-Zusammensetzungen Zusammensetzungen zur Verhinderung von Körpergeruch |
| US20130164352A1 (en) * | 2011-12-22 | 2013-06-27 | The Dial Corporation | Antiperspirant compositions and products effective to facilitate preventing, removing or minimizing fabric stains and methods for making the same |
| DE102012224157A1 (de) * | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textil schonende Antitranspirant-Sprays mit Hydroxycarbonsäuren |
| DE102012224156A1 (de) * | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textil schonende Nonaerosol-Antitranspirantien mit Hydroxycarbonsäuren |
-
2013
- 2013-10-15 DE DE201310220777 patent/DE102013220777A1/de not_active Withdrawn
-
2014
- 2014-09-26 WO PCT/DE2014/200516 patent/WO2015055199A2/fr not_active Ceased
- 2014-09-26 EP EP14796688.1A patent/EP3057567A2/fr not_active Withdrawn
-
2016
- 2016-03-29 US US15/083,461 patent/US20160206529A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2015055199A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015055199A2 (fr) | 2015-04-23 |
| US20160206529A1 (en) | 2016-07-21 |
| WO2015055199A3 (fr) | 2015-08-06 |
| DE102013220777A1 (de) | 2015-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102013225620A1 (de) | Schweißhemmende kosmetische Mittel ohne aluminiumhaltige Verbindungen II | |
| EP2934461A2 (fr) | Sprays antitranspirants ménageant les textiles, contenant des acides hydroxycarboxyiques | |
| DE102015225958A1 (de) | Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen | |
| WO2015085999A1 (fr) | Produit cosmétique anti-transpirant sans composés contenant de l'aluminium | |
| EP3057570B1 (fr) | Utilisation des polysaccharides dans des antiperspirants pour la protection de textiles | |
| EP3057665A1 (fr) | Agent cosmétique anti-transpiration contenant des lactates | |
| EP3057564A1 (fr) | Produit cosmétique anti-transpirant contenant des acides amidosulfoniques | |
| EP3057568B1 (fr) | Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants | |
| WO2014095685A2 (fr) | Sprays antitranspirants ménageant les textiles, contenant de l'acide méthane-sulfonique | |
| DE102015225876A1 (de) | "Deodorantien, enthaltend spezielle kationische Morpholinoverbindungen in Kombination mit bestimmten Deowirkstoffen" | |
| DE102015225892A1 (de) | Deodorantien, enthaltend spezielle cyclische Alkohole in Kombination mit bestimmten Deowirkstoffen | |
| EP3057666A1 (fr) | Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques | |
| EP3057565A2 (fr) | Agent cosmétique anti-transpirant comprenant des acides polycarboxyliques | |
| EP3057566A1 (fr) | Agent cosmétique anti-transpirant contenant des acides polyphosphoriques | |
| WO2014187576A1 (fr) | Association de principes actifs désodorisante | |
| EP3057567A2 (fr) | Produits cosmétiques anti-transpirants aux alpha-hydroxyacides | |
| EP3206657B1 (fr) | Anti-perspirant avec aluminumsesquichlorohydrat et acide citrique triéthylique | |
| DE102014205199A1 (de) | Schweißhemmende kosmetische Mittel enthaltend wasserlösliche Polysaccharide | |
| DE102013225616A1 (de) | Schweißhemmende kosmetische Mittel mit Lysozym und/oder Bovine serum albumin und/oder Yoghurt Protein | |
| DE102013220782A1 (de) | Schweißhemmende kosmetische Mittel mit Phenylcarbonsäuren | |
| DE102011089012A1 (de) | Textilschonende Antitranspirantien | |
| EP2626061A2 (fr) | Procédé de fabrication d'un produit cosmétique avec une phase huileuse épaissie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20160211 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20170329 |